These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29436743)

  • 1. Plasma N-acylethanolamine and endocannabinoid levels in burning mouth syndrome: Potential role in disease pathogenesis.
    Barry A; O'Halloran KD; McKenna JP; McCreary C; Harhen B; Kerr DM; Finn DP; Downer EJ
    J Oral Pathol Med; 2018 Apr; 47(4):440-442. PubMed ID: 29436743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism.
    Fanelli F; Mezzullo M; Repaci A; Belluomo I; Ibarra Gasparini D; Di Dalmazi G; Mastroroberto M; Vicennati V; Gambineri A; Morselli-Labate AM; Pasquali R; Pagotto U
    Mol Metab; 2018 Aug; 14():82-94. PubMed ID: 29935920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma IL-8 signature correlates with pain and depressive symptomatology in patients with burning mouth syndrome: Results from a pilot study.
    Barry A; O'Halloran KD; McKenna JP; McCreary C; Downer EJ
    J Oral Pathol Med; 2018 Feb; 47(2):158-165. PubMed ID: 29194773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-Specific Derangement of Circulating Endocannabinoids and
    Forte D; Fanelli F; Mezzullo M; Barone M; Corradi G; Auteri G; Bartoletti D; Martello M; Ottaviani E; Terragna C; Curti A; Pagotto U; Palandri F; Cavo M; Catani L
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary Endocannabinoid Profiles in Chronic Orofacial Pain and Headache Disorders: An Observational Study Using a Novel Tool for Diagnosis and Management.
    Heiliczer S; Wilensky A; Gaver T; Georgiev O; Hamad S; Nemirovski A; Hadar R; Sharav Y; Aframian DJ; Tam J; Haviv Y
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).
    Hanlon EC
    Psychoneuroendocrinology; 2020 Jan; 111():104471. PubMed ID: 31610409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention.
    Soldevila-Domenech N; Fagundo B; Cuenca-Royo A; Forcano L; Gomis-González M; Boronat A; Pastor A; Castañer O; Zomeño MD; Goday A; Dierssen M; Baghizadeh Hosseini K; Ros E; Corella D; Martínez-González MÁ; Salas-Salvadó J; Fernández-Aranda F; Fitó M; de la Torre R
    Nutr J; 2024 Jun; 23(1):61. PubMed ID: 38862960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of preterm labour from a single blood test: The role of the endocannabinoid system in predicting preterm birth in high-risk women.
    Bachkangi P; Taylor AH; Bari M; Maccarrone M; Konje JC
    Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():1-6. PubMed ID: 31618675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.
    Hill MN; Miller GE; Carrier EJ; Gorzalka BB; Hillard CJ
    Psychoneuroendocrinology; 2009 Sep; 34(8):1257-62. PubMed ID: 19394765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms.
    Comai S; Nunez N; Atkin T; Ghabrash MF; Zakarian R; Fielding A; Saint-Laurent M; Low N; Sauber G; Ragazzi E; Hillard CJ; Gobbi G
    BMC Med; 2024 Jan; 22(1):33. PubMed ID: 38273283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training.
    Bystrowska B; Smaga I; Frankowska M; Filip M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():1-10. PubMed ID: 24334211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Circulating N-Acylethanolamine Levels with Clinical and Laboratory End Points in Hemodialysis Patients.
    Pai AY; Wenziger C; Streja E; Argueta DA; DiPatrizio NV; Rhee CM; Vaziri ND; Kalantar-Zadeh K; Piomelli D; Moradi H
    Am J Nephrol; 2021; 52(1):59-68. PubMed ID: 33601382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.
    Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma E; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V
    Liver Int; 2010 Jul; 30(6):816-25. PubMed ID: 19840245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
    Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
    Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
    Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
    Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry.
    Lam PM; Marczylo TH; Konje JC
    Anal Bioanal Chem; 2010 Nov; 398(5):2089-97. PubMed ID: 20835819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial.
    Schrieks IC; Ripken D; Stafleu A; Witkamp RF; Hendriks HF
    PLoS One; 2015; 10(5):e0126421. PubMed ID: 25962070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants.
    Romero-Sanchiz P; Nogueira-Arjona R; Pastor A; Araos P; Serrano A; Boronat A; Garcia-Marchena N; Mayoral F; Bordallo A; Alen F; Suárez J; de la Torre R; Pavón FJ; Rodríguez de Fonseca F
    Neuropharmacology; 2019 May; 149():212-220. PubMed ID: 30822499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and
    Ferrara AL; Piscitelli F; Petraroli A; Parente R; Galdiero MR; Varricchi G; Marone G; Triggiani M; Di Marzo V; Loffredo S
    J Immunol Res; 2019; 2019():5836476. PubMed ID: 31355297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.
    Hill MN; Bierer LM; Makotkine I; Golier JA; Galea S; McEwen BS; Hillard CJ; Yehuda R
    Psychoneuroendocrinology; 2013 Dec; 38(12):2952-61. PubMed ID: 24035186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.